Literature DB >> 9297114

Outpatient parenteral antimicrobial-drug therapy.

D N Gilbert1, R J Dworkin, S R Raber, J E Leggett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9297114     DOI: 10.1056/NEJM199709183371207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Intravenous long-lines in children with cystic fibrosis: a multidisciplinary approach.

Authors:  Mark A Turner; Veda Unsworth; Timothy J David
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

3.  Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island.

Authors:  Francine Touzard Romo; Brian Resnick; Mildred Perez-Cioe; Timothy P Flanigan; Erna M Kojic; Curt G Beckwith
Journal:  R I Med J (2013)       Date:  2014-01-05

4.  Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Authors:  Camelia E Marculescu; Elie F Berbari; J Robert Cantey; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

Review 5.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

6.  Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis.

Authors:  S Shepperd; D Harwood; A Gray; M Vessey; P Morgan
Journal:  BMJ       Date:  1998-06-13

Review 7.  Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.

Authors:  Richard S Slavik; Peter J Jewesson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Safety and efficacy of long-term outpatient ertapenem therapy.

Authors:  Zubair A Qureshi; Alveena Syed; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

Review 9.  C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option.

Authors:  H J Longhurst; S Carr; K Khair
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

10.  Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.

Authors:  Kavita P Bhavan; L Steven Brown; Robert W Haley
Journal:  PLoS Med       Date:  2015-12-15       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.